Indication
TIL Engineered With Membrane-Binding Cytokine
1 clinical trial
1 product
Clinical trial
A Clinical Study on TIL Engineered With Membrane-Binding Cytokine for the Treatment of Advanced Gynecologic TumorsStatus: Recruiting, Estimated PCD: 2024-03-10